AZmed

AZmed is a French healthcare technology company founded in 2018, specializing in artificial intelligence solutions for medical diagnostics, particularly in radiology. The company aims to support radiologists and doctors by integrating AI into their workflows to save time, improve diagnostic precision, and enhance patient care quality. Its flagship product, Rayvolve®, is an AI-powered radiology software suite that detects pathologies such as fractures and chest diseases on standard X-rays. Rayvolve® employs advanced AI algorithms and deep learning to interpret medical images quickly, enabling early detection of abnormalities and guiding more precise treatment plans. The software integrates seamlessly into clinical workflows, enhancing daily productivity without requiring changes in doctors' habits. AZmed's solutions have been validated by leading clinical institutions and have received regulatory approvals, including the CE IIa MDR mark and FDA approval for fracture detection in the US. The company's AI tools are used in over 250 healthcare institutions across more than 50 countries, with over 2,500 doctors utilizing the software daily.

• Employees 50
• Founded 2018
• Annual Revenue $6000000
• Total Funding $19846470